Cited by 10Treatment of Major DepressionFunctional Brain Connectivity StudiesTranscranial Magnetic Stimulation Studies

Effects of the KCNQ (Kv7) Channel Opener Ezogabine on Resting-State Functional Connectivity of Striatal Brain Reward Regions, Depression, and Anhedonia in Major Depressive Disorder: Results From a Randomized Controlled Trial

Open access
Chowdhury, Avijit, Boukezzi, Sarah, Costi, Sara, Hameed, Sara, Jacob, Yael, Salas, Ramiro, Iosifescu, Dan V., Han, Ming-Hu +4 more·2025·Biological Psychiatry

Abstract

Background Major depressive disorder (MDD) is a leading cause of disability worldwide, with available treatments often showing limited efficacy. Recent research suggests that targeting specific subtypes of depression and understanding the underlying brain mechanisms can improve treatment outcomes. This study investigates the potential of the potassium KCNQ (Kv7) channel opener ezogabine to modulate the resting-state functional connectivity (RSFC) of the brain's reward circuitry and alleviate depressive symptoms, including anhedonia, a core feature of MDD.Methods A double-blind, randomized, placebo-controlled clinical trial in individuals with MDD ages 18 to 65 years compared daily dosing with ezogabine (n= 19) with placebo (n = 21) for 5 weeks. Functional magnetic resonance imaging assessed RSFC of the brain's key reward regions (ventral caudate, nucleus accumbens) at baseline and posttreatment. Clinical symptoms were measured using the Snaith-Hamilton Pleasure Scale (SHAPS), Montgomery-Åsberg Depression Rating Scale (MADRS), and other clinical symptom scales.Results Ezogabine significantly reduced RSFC between the reward seeds and the posterior cingulate cortex (PCC)/precuneus compared with placebo, which was associated with a reduction in depression severity. Improvements in anhedonia (SHAPS) and depressive symptoms (MADRS) with ezogabine compared with placebo were also associated with decreased connectivity between the reward seeds and mid/posterior cingulate regions (midcingulate cortex, PCC, precuneus).Conclusions The findings suggest that ezogabine's antidepressant effects are mediated through modulation of striatal-mid/posterior cingulate connectivity, indicating a potential therapeutic mechanism for KCNQ-targeted drugs for MDD and anhedonia. Future studies should validate these results in larger trials.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2025.02.897

Cites

60 of 60 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In major depressive disorder with prominent anhedonia, ezogabine produced meaningful reductions in depressive symptoms and improved reward sensitivity in randomized and open-label studies, with parallel changes in ventral striatal connectivity and reward learning.

    “In major depressive disorder with prominent anhedonia, ezogabine produced meaningful reductions in depressive symptoms and improved reward sensitivity in randomized and open-label studies, with parallel changes in ventral striatal connectivity and reward learning [259,260,261].”

    From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [259]

    Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [5]Ferguson JM (2001): SSRI antidepressant medications: adverse effects and tolerability. Prim Care Companion J Clin Psychiatry 3: 22. 15014625 PMC181155

Authors
Chowdhury, A., Boukezzi, S., Costi, S., Hameed, S., Jacob, Y., Salas, R., Iosifescu, D. V., Han, M.-H., Swann, A., Mathew, S. J., Morris, L., & Murrough, J. W.
Affiliations
  • Icahn School of Medicine at Mount Sinai (US)
  • Oxford Health NHS Foundation Trust (GB)
  • Michael E. DeBakey VA Medical Center (US)
  • Nathan Kline Institute for Psychiatric Research (US)
  • Shenzhen Institutes of Advanced Technology (CN)
  • Baylor College of Medicine (US)
  • James J. Peters VA Medical Center (US)
Corresponding author
Murrough, James W.
Venue
Biological Psychiatry
Publisher
Elsevier BV
Published
2025-10
Volume
98
Issue
7
Pages
568-577
ISSN
0006-3223 (ISSN-L)
OpenAlex
W4408149262
Cited by
10
References
60
Citations by year
2026: 8 · 2025: 2
FWCI
5.65
Type
journal article
Language
en
Open access
Locations
  • Biological Psychiatry (acceptedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
Funders
  • National Institutes of Health
  • National Institute of Mental Health (R61MH111932)
  • National Key Research and Development Program of China (2021ZD0202902, T2250710685, 2021ZD0202900)
  • National Center for Advancing Translational Sciences (UL1TR001433)
  • Wellcome Trust
  • Natural Science Foundation of Shenzhen Municipality (JCYJ20220818101600001)
Topics
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Functional Brain Connectivity Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
ezogabine, Kv7 channels, major depressive disorder, anhedonia, resting-state functional connectivity, nucleus accumbens, posterior cingulate cortex, precuneus, midcingulate cortex, antidepressant mechanism
MeSH terms
Adolescent, Adult, Aged, Antidepressive Agents, Carbamates, Major Depressive Disorder, Depressive Disorder, Major, Double-Blind Method, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Phenylenediamines, Reward, KCNQ Potassium Channels, Young Adult, Anhedonia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review